...
首页> 外文期刊>Clinical kidney journal. >Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression
【24h】

Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression

机译:血浆中性粒细胞凝胶酶相关的脂素在重症监护室内入院时作为急性肾损伤进展的预测因子

获取原文

摘要

Abstract Background Acute kidney injury (AKI) is a common complication in patients during intensive care unit (ICU) admission. AKI is defined as an increase in serum creatinine (SCr) and/or a reduction in urine output. SCr is a marker of renal function with several limitations, which led to the search for biomarkers for earlier AKI detection. Our aim was to study the predictive value of plasma neutrophil gelatinase-associated lipocalin (NGAL) at admission as a biomarker for AKI progression during the first 48?h of ICU admission in an unselected, heterogeneous ICU patient population. Methods We conducted a prospective observational study in an academic tertiary referral ICU population. We recorded AKI progression in all ICU patients during the first 48?h of ICU admission in a 6-week period. Plasma NGAL was measured at admission but levels were not reported to the attending clinicians. As possible predictors of AKI progression, pre-existing AKI risk factors were recorded. We examined the association of clinical parameters and plasma NGAL levels at ICU admission with the incidence and progression of AKI within the first 48?h of the ICU stay. Results A total of 361 patients were included. Patients without AKI progression during the first 48?h of ICU admission had median NGAL levels at admission of 115?ng/mL [interquartile range (IQR) 81–201]. Patients with AKI progression during the first 48?h of ICU admission had median NGAL levels at admission of 156?ng/mL (IQR 97–267). To predict AKI progression, a multivariant model with age, sex, diabetes mellitus, body mass index, admission type, Acute Physiology and Chronic Health Evaluation score and SCr at admission had an area under the receiver operating characteristics (ROC) curve of 0.765. Adding NGAL to this model showed a small increase in the area under the ROC curve to 0.783 (95% confidence interval 0.714–0.853). Conclusions NGAL levels at admission were higher in patients with progression of AKI during the first 48?h of ICU admission, but adding NGAL levels at admission to a model predicting this AKI progression showed no significant additive value.
机译:摘要背景急性肾损伤(AKI)是重症监护室(ICU)入场期间患者的常见并发症。 AKI被定义为血清肌酐(SCR)的增加和/或尿量减少。 SCR是具有多个限制的肾功能标记,从而导致搜索早期AKI检测的生物标记。我们的目的是研究血浆中性粒细胞明胶酶相关的脂素(NGAL)的预测值,作为AKI进展在未选择的异构ICU患者人群中的第一个48〜6期间AKI进展的生物标志物。方法我们在学术高等教育ICU人口中进行了一项前瞻性观察研究。我们在6周期间在ICU入场的第一个48患者中录制了所有ICU患者的AKI进展。在入院时测量血浆NGAL,但在参加临床医生中没有报告水平。作为AKI进展的可能预测因子,记录了预先存在的AKI风险因素。我们研究了ICU入院ICU入院的临床参数和血浆NGAL水平的关联,在ICU留下的前48岁内部的发病率和进展。结果共有361名患者。没有AKI进展的患者在ICU入院的前48℃的进展中有115μg/ ml [四分位数范围(IQR)81-201]中位NGAL水平。 ICU入院的前48例中AKI进展的患者在入院156?NG / ML(IQR 97-267)中的中位NGAL水平。为了预测AKI进展,具有年龄,性别,糖尿病,体重指数,入学型,急性生理学和入学慢性健康评估得分和SCR的多变量模型在接收器操作特性(ROC)曲线下为0.765。向该模型中添加NGAL显示ROC曲线下的面积较小至0.783(95%置信区间0.714-0.853)。结论在ICU入院的前48℃的AKI进展过程中,入院的NGAL水平较高,但在进入预测该AKI进展的模型中添加NGAL水平显示出没有显着的添加剂值。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号